Please assess the completion status of the following clinical trial:

Trial Title: Mask Adhesive Institutional Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults patients age 18 to 85 (inclusive)~* Adult patients treated with NIV~* Able to read, write, and speak English~* Able to provide written informed consent~* Willing to have facial hair removed for adhesive placement (if required)~Exclusion Criteria:~* Pre-existing allergy to tape or adhesive;~* Blisters, open skin or pre-existing skin condition that may impact the ability to support removal of the mask adhesive without tearing the skin~* pregnant (for females of childbearing age);~* Individuals sentenced to such an institution under a criminal or civil statute,~* Individuals detained in other facilities by virtue of statutes or commitment procedures which provide alternatives to criminal prosecution or incarceration in a penal institution, and individuals detained pending arraignment, trial, or sentencing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Mask with Mask Adhesive/Arm 1 (Type: ACTIVE_COMPARATOR): Patients will be randomized to AF531 if they receive mask adhesive with mask on the first study night then the mask without mask adhesive(Performatrak) on the second study night.
- Mask without Mask Adhesive/Arm 2 (Type: PLACEBO_COMPARATOR): Patients will be randomized to Arm 2 if they receive the mask without mask adhesive on the first study night then they will receive the mask with the mask adhesive on the second study night.

Based on this trial design, predict the completion outcome and termination type (if applicable).